ISSN: 2320-480X
Manuscript Submission

The Journal of Phytopharmacology, 2020;9(4):270-273 ;   DOI:10.31254/phyto.2020.9410

Review Article

Plant secondary metabolites as potential usage in regenerative medicine

Divya Dharshini Umashankar1

1. Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India

*Author to whom correspondence should be addressed.

Received: 27th July, 2019 / Accepted: 22nd June, 2020

Abstract


Plants secondary metabolites have shown a potential usage to treat infections, health disorders, and illness. During the years these had been slowly replaced by other synthetic drugs. Many of these higher plants and their products are major sources of useful in different industries such as pharmaceutical, agrochemical, flavor and other aroma industries. On a worldwide scale, medicinal plants which use secondary metabolites mainly uses as crude drugs and extracts to treat diseases. Several of the plant secondary metabolites have a potent usage from these isolated compounds as including alkaloids such as morphine (pain killer), codeine (antitussive), papaverine (phosphodiesterase inhibitor), ephedrine (stimulant), ajmaline (antiarrhythmic), quinine (antimalarial), reserpine (antihypertensive), galanthamine (acetylcholine esterase inhibitor), scopolamine (travel sickness), berberine (psoriasis), caffeine (stimulant), capsaicin (rheumatic pains), colchicine (gout), yohimbine (aphrodisiac), pilocarpine (glaucoma), and various types of cardiac glycosides [1]. Flavonoids such as anthocyanins (antidiabetic), Naringin (anti osteoporotic), Cocoa flavonols (coronary artery disease), cardamonin(anti-cancerous) helps in treating various diseases.

Keywords

Alkaloids, Terpenes, Alzheimer, Diabetes, Malaria, Cancer, Coronary heart disease, Flavonolsn.


HOW TO CITE THIS ARTICLE

Umashankar DD. Plant Secondary Metabolites as Potential usage in Regenerative Medicine. J Phytopharmacol 2020; 9(4):270-273.

Creative Commons (CC) License-

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).

Copyright

Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.

Technical Support

×